Nasal Immunology and Barrier Function

The nasal mucosa is the body's first immune checkpoint for inhaled air. Its epithelium is both a physical barrier, held together by junctions between cells, and an active sentinel that detects microbes and irritants and recruits the rest of the immune system. This entry describes how the nasal lining keeps harmful material out, how it signals when defences are needed, and how a leaky or dysregulated barrier is thought to contribute to chronic airway inflammation.

Definition

Nasal immunology and barrier function is the study of how the sinonasal mucosa acts as a physical and immunological barrier, combining epithelial tight junctions, mucus and antimicrobial defences, and innate and adaptive immune signalling to protect the airway from inhaled threats.

Scope

The topic covers the structure of the sinonasal epithelial barrier, innate defences (mucus, antimicrobial molecules, pattern-recognition signalling), the link between epithelium and adaptive immunity, and the concept that barrier dysfunction contributes to allergic and chronic inflammatory disease. It is a reference immunology entry, not a diagnostic or therapeutic guide.

Core questions

• What makes the nasal epithelium a barrier, and how do its junctions work?
• What innate defences operate at the nasal surface before adaptive immunity engages?
• How does the epithelium sense danger and recruit immune cells?
• How might a dysfunctional barrier contribute to chronic airway inflammation?

Key concepts

• Epithelial tight junctions
• Mucus and antimicrobial peptides
• Pattern-recognition receptors
• Epithelial alarmins (e.g., cytokine signalling to immune cells)
• Innate versus adaptive mucosal immunity
• Secretory immunoglobulin A
• Barrier dysfunction and chronic inflammation
• Type 2 inflammation in chronic rhinosinusitis

Key theories

Epithelial barrier hypothesis

The proposal that environmental agents that damage epithelial barriers, including in the airway, promote a leaky barrier and dysregulated immune responses, contributing to the rise of allergic and other chronic inflammatory diseases.

Mechanisms

The sinonasal epithelium forms a selective barrier: adjacent cells are sealed by tight junctions that limit the passage of allergens and microbes between cells, while the overlying mucus layer carries antimicrobial peptides, enzymes, and secretory immunoglobulin A that neutralize or trap pathogens. Epithelial cells express pattern-recognition receptors that detect microbial and danger signals; on activation they release mediators that alert and recruit innate and adaptive immune cells, bridging the surface defence to the broader immune response. When the barrier is damaged or its junctions are loosened, allergens and microbes penetrate more readily and epithelial signalling can drive sustained inflammation; the epithelial barrier hypothesis frames this as a contributor to chronic allergic and inflammatory airway disease, including the type 2 inflammation seen in some chronic rhinosinusitis.

Clinical relevance

Nasal barrier and immune biology provide the conceptual basis for understanding chronic rhinosinusitis and allergic rhinitis as disorders involving epithelial and immune dysregulation, not merely structural blockage. This entry describes mechanisms for educational purposes and does not provide diagnostic criteria or treatment recommendations, which require individual clinical assessment.

Evidence & guidelines

Mucosal barrier and immune mechanisms are reviewed in immunology literature, including statements of the epithelial barrier hypothesis, and are integrated into rhinology consensus documents such as the ICAR rhinosinusitis statement and EPOS 2020, which frame inflammatory endotypes of sinonasal disease.

History

Early understanding of nasal defence centred on mucus and mucociliary clearance. Over recent decades the epithelium itself came to be seen as an active immune organ that senses danger and shapes inflammation, and the epithelial barrier hypothesis articulated a unifying account linking barrier damage to the rise of chronic inflammatory and allergic disease.

Key figures

• Cezmi Akdis

Seminal works

• akdis-2022
• orlandi-2016-icar

Frequently asked questions

How is the nasal mucosa a barrier?

Its epithelial cells are sealed together by tight junctions and covered by a protective mucus layer carrying antimicrobial molecules and secretory immunoglobulin A, which together limit the entry of allergens and microbes.

What is the epithelial barrier hypothesis?

It is the proposal that environmental agents which damage epithelial barriers make them leaky and trigger dysregulated immune responses, contributing to the increasing prevalence of allergic and other chronic inflammatory diseases.